Fungus Surgery In Gandhi Hospital Successfully sakshi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sakshi.com Daily Mail and Mail on Sunday newspapers.
Neeta Erinjeri, MD is recognized by Continental Who s Who
News provided by
Share this article
Share this article
MIAMI, April 20, 2021 /PRNewswire/ Neeta Erinjeri, MD, is being recognized by Continental Who s Who as a Top Distinguished Doctor in the field of Medicine in acknowledgment for her exceptional work as a Surgical Oncologist with Miami Cancer Institute at Baptist Health South Florida.
At Miami Cancer Institute, the world-renowned cancer specialists and subspecialists work together across numerous medical disciplines to provide the highest standard of patient-centered care. Patients are offered precise, personalized treatment plans that incorporate groundbreaking discoveries and collaborations with other world-renowned cancer researchers. With a unique partnership with Memorial Sloan Kettering, both work diligently to share educational resources and new techniques to further advance cancer care.
E-Mail
Credit: University of Cincinnati
PORTLAND, OR - A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn t live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according to trial results published in
JAMA Oncology.
While the trial findings did not show a direct patient benefit, they do show that it s possible to safely administer chemotherapy prior to pancreatic cancer surgery. They also pave the way for better treatment testing for this notorious killer. With no symptoms in the early stages, and few effective therapies, pancreatic cancer is the fourth-most deadly cancer type in the United States. According to the American Cancer Society, only 20 percent of pancreatic cancer patients are alive one year after diagnosis. After five years, only about 7 percent are alive.